These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21112710)

  • 21. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI).
    Nishie A; Tajima T; Ishigami K; Ushijima Y; Okamoto D; Hirakawa M; Nishihara Y; Taketomi A; Hatakenaka M; Irie H; Yoshimitsu K; Honda H
    J Magn Reson Imaging; 2010 Feb; 31(2):373-82. PubMed ID: 20099351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superparamagnectic iron oxide-enhanced magnetic resonance for tumor surveillance in cirrhotic liver before liver transplantation with explanted liver correlation.
    Tsang LL; Chen CL; Huang TL; Chen TY; Ou HY; Eng HL; Concejero A; Yu CY; Chen HL; Cheng YF
    Transplant Proc; 2011 Jun; 43(5):1674-7. PubMed ID: 21693256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
    Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
    Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.
    Kim S; Mannelli L; Hajdu CH; Babb JS; Clark TW; Hecht EM; Taouli B
    J Magn Reson Imaging; 2010 Feb; 31(2):348-55. PubMed ID: 20099348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does T2-weighted MR imaging improve preoperative detection of malignant hepatic tumors? Observer performance study in 49 surgically proven cases.
    Kondo H; Kanematsu M; Itoh K; Ito K; Maetani Y; Goshima S; Matsuo M; Matsunaga N; Konishi J; Hoshi H; Moriyama N
    Magn Reson Imaging; 2005 Jan; 23(1):89-95. PubMed ID: 15733793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.
    Korpraphong P; Leyendecker JR; Hildebolt CF; Narra V; Bae KT; Brown JJ
    J Med Assoc Thai; 2009 Apr; 92(4):548-55. PubMed ID: 19374308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI findings of recurrent hepatocellular carcinoma after liver transplantation: preliminary results.
    Lee CH; Brubaker LM; Gerber DA; Ku YM; Kim YH; Shin SS; Semelka RC
    J Magn Reson Imaging; 2011 Jun; 33(6):1399-405. PubMed ID: 21591009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT.
    Baek CK; Choi JY; Kim KA; Park MS; Lim JS; Chung YE; Kim MJ; Kim KW
    Clin Radiol; 2012 Feb; 67(2):148-56. PubMed ID: 21920517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma missed on gadolinium enhanced MR imaging, discovered in liver explants: retrospective evaluation.
    Karadeniz-Bilgili MY; Braga L; Birchard KR; Gerber D; Firat Z; Woosley JT; Shrestha R; Semelka RC
    J Magn Reson Imaging; 2006 Feb; 23(2):210-5. PubMed ID: 16416439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of hepatocellular carcinoma and hepatic metastasis from cysts and hemangiomas with calculated T2 relaxation times and the T1/T2 relaxation times ratio.
    Farraher SW; Jara H; Chang KJ; Ozonoff A; Soto JA
    J Magn Reson Imaging; 2006 Dec; 24(6):1333-41. PubMed ID: 17083093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma.
    Fowler KJ; Karimova EJ; Arauz AR; Saad NE; Brunt EM; Chapman WC; Heiken JP
    Transplantation; 2013 Jun; 95(12):1506-11. PubMed ID: 23778569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging Requirements for Utilization of T2*-Weighted Magnetic Resonance Imaging for Identification of Hepatocellular Carcinoma in Cirrhosis: Effect of Hepatic Iron Content.
    Hardie AD; Morgan AE
    J Comput Assist Tomogr; 2015; 39(4):468-72. PubMed ID: 26182222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study.
    Han S; Choi JI; Park MY; Choi MH; Rha SE; Lee YJ
    Korean J Radiol; 2018; 19(4):568-577. PubMed ID: 29962863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of dynamic subtraction MRI in detection of hepatocellular carcinoma.
    Seçil M; Obuz F; Altay C; Gencel O; Iğci E; Sağol O; Dicle O
    Diagn Interv Radiol; 2008 Dec; 14(4):200-4. PubMed ID: 19061165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targetoid appearance on T2-weighted imaging and signs of tumor vascular involvement: diagnostic value for differentiating HCC from other primary liver carcinomas.
    Cannella R; Fraum TJ; Ludwig DR; Borhani AA; Tsung A; Furlan A; Fowler KJ
    Eur Radiol; 2021 Sep; 31(9):6868-6878. PubMed ID: 33590319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of the sensitivity of MRI at detecting hepatocellular carcinoma in cirrhotic patients utilizing an explant reference standard.
    Hanna RF; Ward TJ; Chow DS; Lagana SM; Moreira RK; Emond JC; Weintraub JL; Prince MR
    Clin Imaging; 2014; 38(5):693-7. PubMed ID: 24997104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic Volume Assessment of Hepatocellular Carcinoma in Rat Livers Using a Clinical 3T MRI and Novel Segmentation.
    Orci LA; Oldani G; Lacotte S; Slits F; Friedli I; Wirth W; Toso C; Vallée JP; Crowe LA
    J Invest Surg; 2018 Feb; 31(1):44-53. PubMed ID: 28107094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of spatial resolution of T2-weighted imaging on diagnostic efficacy of MRI in detection of papilledema.
    Sotoudeh H; Bowerson M; Parsons M; VanStavern G; Viets R; Hildebolt C; Sharma A
    AJR Am J Roentgenol; 2015 Mar; 204(3):602-7. PubMed ID: 25714291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood oxygen level-dependent liver MRI: can it predict microvascular invasion in HCC?
    Jhaveri KS; Cleary SP; Fischer S; Haider MA; Pargoankar V; Khalidi K; Moshonov H; Gallinger S
    J Magn Reson Imaging; 2013 Mar; 37(3):692-9. PubMed ID: 23125092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.